These all drugs falls under competitive inhibitors and founded to be responsible for about 70% of inhibition of plasma DPP-4 with some reported side effects such as nasopharyngitis, respiratory tract infections, headache and major setback is founded to be pancreatitis and hypersensitive reactions [68]. The gene discussed is DPP4; the disease is pancreatitis.